Surprisingly, we found that, similar to the recommended hypoglycemic drug of insulin, the use of metformin or sulfonylureas was also the independently protective factor for the long-term all-cause death in patients with pulmonary TB and type 2 diabetes comorbidity. The gene discussed is INS; the disease is pulmonary tuberculosis.